Analysis of Sleep & Recovery Following Rotator Cuff Repair Surgery
Launched by NEW YORK PRESBYTERIAN HOSPITAL · Oct 1, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how a special device can help people sleep better after having surgery to repair a rotator cuff tear in their shoulder. After this type of surgery, many patients struggle to find a comfortable sleeping position because of pain and movement restrictions in their shoulder. The study aims to see if this device can help patients position their arm safely while they sleep, which could make their recovery easier and improve their overall sleep quality.
To be eligible for the trial, participants must have a rotator cuff tear, but those who have had previous shoulder surgery or have certain neurological issues in the same arm will not be able to join. The trial is open to both men and women aged 65 to 74, and it is currently not yet recruiting participants. If you take part in this study, you can expect to use the sleep device and share your experiences to help researchers understand its benefits for recovery after shoulder surgery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Rotator Cuff Tear
- Exclusion Criteria:
- • Prior ipsilateral shoulder surgery
- • Ipsilateral upper extremity neurological deficit
About New York Presbyterian Hospital
NewYork-Presbyterian Hospital is a premier academic medical center renowned for its commitment to advancing healthcare through innovative research and clinical trials. Affiliated with two Ivy League institutions, Columbia University Vagelos College of Physicians and Surgeons and Weill Cornell Medicine, the hospital leverages cutting-edge technology and a multidisciplinary approach to improve patient outcomes across a wide range of medical specialties. With a focus on translating scientific discoveries into effective treatments, NewYork-Presbyterian actively engages in clinical trials that address critical health challenges, ensuring access to the latest therapies for patients while contributing to the advancement of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported